Risk | Very High | Very High |
Rating | 2.0 | 4.0 |
Min SIP Amount | ₹100 | ₹500 |
Expense Ratio | 2.28 | 1.95 |
NAV | ₹29.84 | ₹408.70 |
Fund Started | 20 Jun 2019 | 04 Jun 1999 |
Fund Size | ₹881.52 Cr | ₹3416.13 Cr |
Exit Load | Exit load of 1% if redeemed within 30 days. | Exit load of 0.50% if redeemed within 15 days |
1 Year | 34.56% | 42.15% |
3 Year | 16.65% | 22.59% |
5 Year | 23.51% | 28.44% |
Equity | 93.63% | 96.73% |
Cash | 6.37% | 3.27% |
Top 10 Holdings |
|
|
Name | Dhaval Joshi | Tanmaya Desai |
Start Date | 21 Nov 2022 | 27 Jun 2011 |
Description | The scheme seeks to provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India. | The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space. |
Launch Date | 20 Jun 2019 | 04 Jun 1999 |